Study on changes and mechanisms of cytokines for alloxan-induced hepatic injury by Cr3+-treatment in mice

다국어 초록 (Multilingual Abstract)

This study investigated the effects of treatment with trivalent chromium (Cr3+) on the cytokine levels in mice that had alloxan-induced hepatic injury.
The results showed that chromium picolinate (CrPic) may have a protective effect against hepatic injury and that these effects might be related to changes in cytokine expression. Blood ALT and AST levels in the alloxan mice were higher than those in the control and CrPic-treated groups (no significant differences between the latter groups). Luminex assays of cytokines from Th1 (TNF-α, IL-2 and IL-9) and Th2 (IL-3, IL- 5, IL-6, IL-10, IL-13) - as well as G-CSF, M-CSF, and GM-CSF - demonstrated increased levels of TNF-α, IL-2, and IL-9 (55.10%, 1.05-fold, and 2.14-fold, respectively) in alloxan-treated mice compared to control mice. Further, compared to the control group, liver IL- 3, -5, -6, -10, and -13 levels were decreased 2.45-fold, 1.54-fold, 1.01-fold, 12.6% and 37.3%, respectively, in the alloxan-treated mice. In comparison to the control mice, the levels of G-CSF, M-CSF and GM-CSF were decreased in the alloxan-treated mice (25.2%, 49.5%, and 52.9%, respectively). These cytokines were increased 7.91-fold, 43.67% and 34.05%, respectively, in the CrPic-treated group. These findings suggest that Th1/Th2 type cytokines are involved in hepatic injury and induced by alloxan, which may provide a new possible therapeutic approach through CrPic-treatment.

참고문헌 (Reference)

1 Ledebur, H. C., "Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65homodimers" 270 : 933-943, 1995

2 Chen, C. C., "Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B" (Suppl 47) : 135-141, 1995

3 Nel, A., "Toxic potential of materials at the nano-level" 311 : 622-627, 2006

4 Jagannathan, M, "Toll-like receptors regulate B-cell cytokine production in patients with diabetes" 53 : 1461-1471, 2010

5 Helwig, B. G., "Tissue and circulating expression of IL-1 family members following heat stroke" 43 : 1096-1104, 2011

6 Lenzen, S., "Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin" 42 : 1385-1391, 1991

7 Song, Y. S., "Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat" 12 : 115-122, 2013

8 Chan, C. C., "The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation" 7 : e50577-, 2012

9 King, G. L., "The role of inflammatory cytokines in diabetes and its complications" 79 (79): 1527-1534, 2008

10 Liu, A. J., "The protective effects of collagen peptide-chromium(III)complex on alloxan-induced hepatic injury in mice" 28 : 487-493, 2006

11 Dogukan, A., "The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats" 131 : 124-132, 2009

12 Sheu, S. S., "Targeting antioxidants to mitochondria: A new therapeutic direction" 1762 : 256-265, 2006

13 Bunda, S., "SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptor" 8 : e76370-, 2013

14 Kaneto, H., "Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis" 11-, 2010

15 Bettini, M., "Regulatory T cells and inhibitory cytokines in autoimmunity" 21 : 612-618, 2009

16 Circu, M. L., "Reactive oxygen species, cellular redox systems, and apoptosis" 48 : 749-762, 2010

17 Bartlett, H. E., "Nutritional supplementation for type 2 diabetes: a systematic review" 28 : 503-523, 2008

18 Kasper, L. H., "Multiple sclerosis immunology:The healthy immune system vs the MS immune system" 74 (74): S2-S8, 2010

19 Akash, M. S., "Interleukin-1 receptor antagonist: a new therapy for type 2diabetes mellitus" 101 : 1647-1658, 2012

20 Fernandez-Real, J. M., "Insulin resistance and chronic cardiovascular inflammatory syndrome" 24 : 278-301, 2003

21 Mahmoud, F., "Inflammatory cytokines and the risk of cardiovascular complications in type 2diabetes" 35 : 235-241, 2013

22 Dandona, P., "Inflammation:the link between insulin resistance, obesity, and diabetes" 25 : 4-7, 2004

23 Hooper, P. L., "Inflammation, heat shock proteins, and type 2 diabetes" 14 : 113-115, 2009

24 Skopińsk, P., "Increased IL-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy" 19 : 335-338, 2005

25 Mandrup-Poulsen, T., "IAPP boosts islet macrophage IL-1 in type 2 diabetes" 11 : 881-883, 2010

26 Jain, S. K., "High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes" 9 : 1581-1590, 2007

27 Nakayamada, S., "Helper T cell diversity and plasticity" 24 : 297-302, 2012

28 Lee, S. T., "Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia" 1058 : 120-128, 2005

29 Sakaguchi, S., "Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease" 212 : 8-27, 2006

30 Nosratabadi, R., "Evaluation of IFN serum level in nephropatic Type 2 diabetic patients" 12 : 746-749, 2009

31 Lim, Y. H., "Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima fatty rats" 10 : 92-, 2011

32 Neri, S., "Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes" 49 : 409-416, 2010

33 Rendon, D. A., "Early hyperglycemia following alloxan administration in vivo is not associated with altered hepatic mitochondrial function: acceptable model for type 1 diabetes?" 89 : 477-484, 2011

34 Alan R. Doster, "Distribution and characterization of IL-10-secreting cells in lymphoid tissues of PCV2-infected pigs" 대한수의학회 11 (11): 177-183, 2010

35 Lebovitz, H. E., "Diagnosis, classification, and pathogenesis of diabetes mellitus" 62 (62): 5-9, 2001

36 Hotamisligil, G. S., "Diabetes mellitus: a fundamental and clinical text" Lippincott, Williams and Wilkins 953-962, 2004

37 Wang, W., "Development of diabetes in lean Ncb5ornull mice is associated with manifestations of endoplasmic reticulum and oxidative stress in cells" 1812 : 1532-1541, 2011

38 Preuss, H. G., "Comparing metabolic effects of six different commercial trivalent chromium compounds" 108 : 1986-1990, 2002

39 Anderson, R. A., "Chromium, glucose intolerance and diabetes" 17 : 548-555, 1998

40 Hummel, M., "Chromium in metabolic and cardiovascular disease" 39 : 743-751, 2007

41 Pichler, M., "Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin" 59 : 1008-1016, 2012

42 Graber, J. J., "Biomarkers of disease activity in multiple sclerosis" 305 : 1-10, 2011

43 Corkey, B. E., "Banting lecture 2011: hyperinsulin emia:cause or consequence?" 61 : 4-13, 2011

44 Dahech, I., "Anti-diabetic activity of levan polysaccharide in alloxan-induced diabetic rats" 49 : 742-746, 2011

45 Martins, T. B., "Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay" 136 : 696-704, 2011

46 Hotamisligil, G. S., "Adipose expression of tumor necrosis factor-alpha:direct role in obesity-linked insulin resistance" 259 : 87-91, 1993

47 Sheth, S. G., "AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection" 93 : 44-48, 1998

48 Reitman, S., "A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases" 28 : 56-63, 1957